Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Computed Tomography Market

ID: MRFR/HC/62413-CR
166 Pages
Rahul Gotadki
Last Updated: March 28, 2026

US Computed Tomography (CT) Market Research Report: Size, Share, Trend Analysis By Types (Conventional Scanners (Low Slice, Medium Slice, High Slice), Cone Beam Scanners), By Applications (Oncology, Neurology, Cardiovascular, Musculoskeletal, Abdominal and Pelvic, Others), By End Users (Hospitals, Specialty Centers, Diagnostic and Imaging Center), by Distribution Channel (Online Channels, Offline Channels) and Region (Northeast, Midwest, South, West)) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Computed Tomography Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Billion)
  49.     4.1.1 Oncology
  50.     4.1.2 Cardiology
  51.     4.1.3 Neurology
  52.     4.1.4 Musculoskeletal
  53.     4.1.5 Pulmonary
  54.   4.2 Healthcare, BY End Use (USD Billion)
  55.     4.2.1 Hospitals
  56.     4.2.2 Diagnostic Imaging Centers
  57.     4.2.3 Research Institutions
  58.     4.2.4 Outpatient Facilities
  59.   4.3 Healthcare, BY Technology (USD Billion)
  60.     4.3.1 Computed Tomography Angiography
  61.     4.3.2 Dual Energy Computed Tomography
  62.     4.3.3 Cone Beam Computed Tomography
  63.     4.3.4 Portable Computed Tomography
  64.   4.4 Healthcare, BY Product Type (USD Billion)
  65.     4.4.1 Standalone Computed Tomography Systems
  66.     4.4.2 Mobile Computed Tomography Systems
  67.     4.4.3 Integrated Computed Tomography Systems
  68.   4.5 Healthcare, BY Patient Age Group (USD Billion)
  69.     4.5.1 Pediatric
  70.     4.5.2 Adult
  71.     4.5.3 Geriatric
  72. 5 SECTION V: COMPETITIVE ANALYSIS
  73.   5.1 Competitive Landscape
  74.     5.1.1 Overview
  75.     5.1.2 Competitive Analysis
  76.     5.1.3 Market share Analysis
  77.     5.1.4 Major Growth Strategy in the Healthcare
  78.     5.1.5 Competitive Benchmarking
  79.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  80.     5.1.7 Key developments and growth strategies
  81.       5.1.7.1 New Product Launch/Service Deployment
  82.       5.1.7.2 Merger & Acquisitions
  83.       5.1.7.3 Joint Ventures
  84.     5.1.8 Major Players Financial Matrix
  85.       5.1.8.1 Sales and Operating Income
  86.       5.1.8.2 Major Players R&D Expenditure. 2023
  87.   5.2 Company Profiles
  88.     5.2.1 GE Healthcare (US)
  89.       5.2.1.1 Financial Overview
  90.       5.2.1.2 Products Offered
  91.       5.2.1.3 Key Developments
  92.       5.2.1.4 SWOT Analysis
  93.       5.2.1.5 Key Strategies
  94.     5.2.2 Siemens Healthineers (US)
  95.       5.2.2.1 Financial Overview
  96.       5.2.2.2 Products Offered
  97.       5.2.2.3 Key Developments
  98.       5.2.2.4 SWOT Analysis
  99.       5.2.2.5 Key Strategies
  100.     5.2.3 Philips Healthcare (US)
  101.       5.2.3.1 Financial Overview
  102.       5.2.3.2 Products Offered
  103.       5.2.3.3 Key Developments
  104.       5.2.3.4 SWOT Analysis
  105.       5.2.3.5 Key Strategies
  106.     5.2.4 Canon Medical Systems (US)
  107.       5.2.4.1 Financial Overview
  108.       5.2.4.2 Products Offered
  109.       5.2.4.3 Key Developments
  110.       5.2.4.4 SWOT Analysis
  111.       5.2.4.5 Key Strategies
  112.     5.2.5 Hitachi Medical Systems (US)
  113.       5.2.5.1 Financial Overview
  114.       5.2.5.2 Products Offered
  115.       5.2.5.3 Key Developments
  116.       5.2.5.4 SWOT Analysis
  117.       5.2.5.5 Key Strategies
  118.     5.2.6 Fujifilm Medical Systems (US)
  119.       5.2.6.1 Financial Overview
  120.       5.2.6.2 Products Offered
  121.       5.2.6.3 Key Developments
  122.       5.2.6.4 SWOT Analysis
  123.       5.2.6.5 Key Strategies
  124.     5.2.7 Carestream Health (US)
  125.       5.2.7.1 Financial Overview
  126.       5.2.7.2 Products Offered
  127.       5.2.7.3 Key Developments
  128.       5.2.7.4 SWOT Analysis
  129.       5.2.7.5 Key Strategies
  130.     5.2.8 Neusoft Medical Systems (US)
  131.       5.2.8.1 Financial Overview
  132.       5.2.8.2 Products Offered
  133.       5.2.8.3 Key Developments
  134.       5.2.8.4 SWOT Analysis
  135.       5.2.8.5 Key Strategies
  136.   5.3 Appendix
  137.     5.3.1 References
  138.     5.3.2 Related Reports
  139. 6 LIST OF FIGURES
  140.   6.1 MARKET SYNOPSIS
  141.   6.2 US MARKET ANALYSIS BY APPLICATION
  142.   6.3 US MARKET ANALYSIS BY END USE
  143.   6.4 US MARKET ANALYSIS BY TECHNOLOGY
  144.   6.5 US MARKET ANALYSIS BY PRODUCT TYPE
  145.   6.6 US MARKET ANALYSIS BY PATIENT AGE GROUP
  146.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  147.   6.8 RESEARCH PROCESS OF MRFR
  148.   6.9 DRO ANALYSIS OF HEALTHCARE
  149.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  150.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  151.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  152.   6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  153.   6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  154.   6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
  155.   6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
  156.   6.17 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  157.   6.18 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
  158.   6.19 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  159.   6.20 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
  160.   6.21 HEALTHCARE, BY PATIENT AGE GROUP, 2024 (% SHARE)
  161.   6.22 HEALTHCARE, BY PATIENT AGE GROUP, 2024 TO 2035 (USD Billion)
  162.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  163. 7 LIST OF TABLES
  164.   7.1 LIST OF ASSUMPTIONS
  165.     7.1.1
  166.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  167.     7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  168.     7.2.2 BY END USE, 2026-2035 (USD Billion)
  169.     7.2.3 BY TECHNOLOGY, 2026-2035 (USD Billion)
  170.     7.2.4 BY PRODUCT TYPE, 2026-2035 (USD Billion)
  171.     7.2.5 BY PATIENT AGE GROUP, 2026-2035 (USD Billion)
  172.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  173.     7.3.1
  174.   7.4 ACQUISITION/PARTNERSHIP
  175.     7.4.1

US Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2026-2035)

  • Oncology
  • Cardiology
  • Neurology
  • Musculoskeletal
  • Pulmonary

Healthcare By End Use (USD Billion, 2026-2035)

  • Hospitals
  • Diagnostic Imaging Centers
  • Research Institutions
  • Outpatient Facilities

Healthcare By Technology (USD Billion, 2026-2035)

  • Computed Tomography Angiography
  • Dual Energy Computed Tomography
  • Cone Beam Computed Tomography
  • Portable Computed Tomography

Healthcare By Product Type (USD Billion, 2026-2035)

  • Standalone Computed Tomography Systems
  • Mobile Computed Tomography Systems
  • Integrated Computed Tomography Systems

Healthcare By Patient Age Group (USD Billion, 2026-2035)

  • Pediatric
  • Adult
  • Geriatric

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓